Skip to main content

Advertisement

SpringerLink
Log in

High-risk individuals’ perceptions of reproductive genetic testing for CDH1 mutations

  • Short Communication
  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Reproductive genetic testing- PreNatal Diagnosis (PND) and Preimplantation Genetic Diagnosis (PGD)—for CDH1 mutations associated with Hereditary Diffuse Gastric Cancer (HDGC)is available in the UK. This qualitative interview study examined high-risk individuals’ (n = 35) views of CDH1 reproductive genetic testing. Interviewees generally regarded reproductive genetic testing as an acceptable form of HDGC risk management. However, some were concerned that their genetic risks required them to plan reproduction and anticipated difficulties communicating this to reproductive partners. Individuals had a preference for PGD over PND because it avoided the need for a termination of pregnancy. However, those who had not yet had children expressed concerns about having to undergo IVF procedures and worries about their effectiveness and the need for embryo selection in PGD. It is suggested that high-risk individuals are provided with access to reproductive genetic counselling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. van der Post RS, Vogelaar IP, Carneiro F et al (2015) Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1mutation carriers. J Med Genet 52:361–374

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hansford S, Kaurah P, Li-Chang H, et al., (2015) Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol doi:10.1001/jamaoncol.2014.168

    PubMed  Google Scholar 

  3. Quinn GP, Vadaparampil ST, King LM et al (2009) Conflict between values and technology: perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer. Fam Cancer 8:441–449

    Article  PubMed  Google Scholar 

  4. Ormondroyd E, Donnelly L, Moynihan C et al (2012) Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis. Eur J Hum Genet 20:4–10

    Article  PubMed  Google Scholar 

  5. Quinn GP, Pal T, Murphy D (2012) High-risk consumers’ perceptions of preimplantation genetic diagnosis for hereditary cancers: a systematic review and meta-analysis. Genet Med 14:191–200

    Article  PubMed  Google Scholar 

  6. Douma KF, Aaronson NK, Vasen HF (2010) Attitudes toward genetic testing in childhood and reproductive decision-making for familial adenomatous polyposis. Eur J Hum Genet 18:186–193

    Article  PubMed  Google Scholar 

  7. Hallowell N, Badger S Richardson S et al (2016) An investigation of the factors effecting high-risk individuals’ decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC). Fam Cancer. doi:10.1007/s10689-016-9910-8

    PubMed  Google Scholar 

  8. Strauss A, Corbin J (1990) Basics of qualitative research. Sage, London

    Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the support of the Sir Halley Stewart Trust. The FGCS is funded by infrastructure grants to the Cambridge NIHR BRC and the Cancer Research UK funded ECMC at the University of Cambridge. The views and opinions expressed are the authors and do not necessarily reflect those of NIHR, the NHS or the Department of Health. The authors thank all the interviewees.

Author information

Authors and Affiliations

  1. Ethox Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK

    Nina Hallowell & Richard H. Hardwick

  2. PHG Foundation and Institute of Public Health, University of Cambridge, Cambridge, UK

    Shirlene Badger & Richard H. Hardwick

  3. Cambridge University Hospitals Trust, Addenbrookes Hospital, Cambridge, UK

    Sue Richardson, Carlos Caldas, Richard H. Hardwick & Rebecca C. Fitzgerald

  4. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK

    Sue Richardson, Carlos Caldas & Richard H. Hardwick

  5. MRC Cancer Unit, University of Cambridge, Cambridge, UK

    Richard H. Hardwick & Rebecca C. Fitzgerald

  6. Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK

    Richard H. Hardwick & Julia Lawton

Authors
  1. Nina Hallowell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shirlene Badger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sue Richardson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlos Caldas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard H. Hardwick
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rebecca C. Fitzgerald
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Julia Lawton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nina Hallowell.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hallowell, N., Badger, S., Richardson, S. et al. High-risk individuals’ perceptions of reproductive genetic testing for CDH1 mutations. Familial Cancer 16, 531–535 (2017). https://doi.org/10.1007/s10689-017-9976-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-017-9976-y

Keywords

Search

Navigation